Home Resources Biotech and Pharmaceutical 2020 Report - Research Report by BlueVoyant Biotech and Pharmaceutical 2020 Report – Research Report by BlueVoyant December 11, 2020 BlueVoyant Report Reveals Biotech and Pharmaceutical Industry under Aggressive and Targeted Attack As the industry ramps up global vaccine production and distribution, the report highlights the attack types and emerging threats that are likely to intensify. Key findings include: The No. 1 emerging threat in 2020 is nation-state espionage aimed at stealing COVID-19 vaccine research data. That said, the top threat overall is still ransomware. COVID-19 vaccines are the crown jewels in 2020 with eight of the most prominent companies in the race for a vaccine facing high volumes of targeted malicious attacks. Analysis of threat intelligence data shows that biotech and pharmaceutical companies are under massive and daily attack Of the 25 attacks reported to the media since 2017, 10 (40%) took place in 2020. Read more around the key implications that the biotech and pharmaceutical industries are facing and how to monitor and mitigate these new attack vectors during the most critical time in their existence. Download this Resource Share: Facebook Twitter LinkedIn Related reading BlueVoyant Corporate BlueVoyant and Bytes Partner to Deliver Managed Third-Party Cyber Risk Management to UK&I Organizations November 23, 2021 This partnership brings BlueVoyant’s advanced, turnkey third-party risk management solution into the Bytes cybersecurity solution portfolio. Read more Malware AnchorDNS Comes Ashore: Evolutions in the TTPs of TrickBot November 12, 2021 Using our knowledge of AnchorDNS-now-Stickseed, BlueVoyant Third-Party Risk and Managed Security Services were able to identify a Stickseed attack in the… Read more Events Gartner Security and Risk Management Summit 2021 – EMEA November 29, 2021 Join us for our “Operationalizing Third-Party Cyber Risk Management” session at 12:45 p.m. GMT, December 1. Read more Recommended reading Report Managing Cyber Risk Across the Extended Vendor Ecosystem BlueVoyant released “Global Insights – Managing Cyber Risk Across the Extended Vendor Ecosystem,” its second annual global survey into third-party cyber… Learn more
December 11, 2020 BlueVoyant Report Reveals Biotech and Pharmaceutical Industry under Aggressive and Targeted Attack As the industry ramps up global vaccine production and distribution, the report highlights the attack types and emerging threats that are likely to intensify. Key findings include: The No. 1 emerging threat in 2020 is nation-state espionage aimed at stealing COVID-19 vaccine research data. That said, the top threat overall is still ransomware. COVID-19 vaccines are the crown jewels in 2020 with eight of the most prominent companies in the race for a vaccine facing high volumes of targeted malicious attacks. Analysis of threat intelligence data shows that biotech and pharmaceutical companies are under massive and daily attack Of the 25 attacks reported to the media since 2017, 10 (40%) took place in 2020. Read more around the key implications that the biotech and pharmaceutical industries are facing and how to monitor and mitigate these new attack vectors during the most critical time in their existence. Download this Resource Share: Facebook Twitter LinkedIn Related reading BlueVoyant Corporate BlueVoyant and Bytes Partner to Deliver Managed Third-Party Cyber Risk Management to UK&I Organizations November 23, 2021 This partnership brings BlueVoyant’s advanced, turnkey third-party risk management solution into the Bytes cybersecurity solution portfolio. Read more Malware AnchorDNS Comes Ashore: Evolutions in the TTPs of TrickBot November 12, 2021 Using our knowledge of AnchorDNS-now-Stickseed, BlueVoyant Third-Party Risk and Managed Security Services were able to identify a Stickseed attack in the… Read more Events Gartner Security and Risk Management Summit 2021 – EMEA November 29, 2021 Join us for our “Operationalizing Third-Party Cyber Risk Management” session at 12:45 p.m. GMT, December 1. Read more Recommended reading Report Managing Cyber Risk Across the Extended Vendor Ecosystem BlueVoyant released “Global Insights – Managing Cyber Risk Across the Extended Vendor Ecosystem,” its second annual global survey into third-party cyber… Learn more
BlueVoyant Corporate BlueVoyant and Bytes Partner to Deliver Managed Third-Party Cyber Risk Management to UK&I Organizations November 23, 2021 This partnership brings BlueVoyant’s advanced, turnkey third-party risk management solution into the Bytes cybersecurity solution portfolio. Read more
Malware AnchorDNS Comes Ashore: Evolutions in the TTPs of TrickBot November 12, 2021 Using our knowledge of AnchorDNS-now-Stickseed, BlueVoyant Third-Party Risk and Managed Security Services were able to identify a Stickseed attack in the… Read more
Events Gartner Security and Risk Management Summit 2021 – EMEA November 29, 2021 Join us for our “Operationalizing Third-Party Cyber Risk Management” session at 12:45 p.m. GMT, December 1. Read more
Report Managing Cyber Risk Across the Extended Vendor Ecosystem BlueVoyant released “Global Insights – Managing Cyber Risk Across the Extended Vendor Ecosystem,” its second annual global survey into third-party cyber… Learn more
